Dow Jones

38 699,94

0,29%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Contravir Pharmaceuticals (MM) (CTRV)
Contravir Pharmaceuticals (MM) (CTRV) Actualités

CTRV

Contravir Pharmaceuticals Inc (CTRV)

Contravir Pharmaceuticals (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:CTRV

1 2 3 4 5 6 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
08/11/2019	12h06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
21/10/2019	22h26	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
14/08/2019	23h30	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
29/07/2019	22h15	GlobeNewswire Inc.	Hepion Pharmaceuticals Receives FDA Authorization to Proceed with IND Opening Study of CRV431 for NASH	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
25/07/2019	22h17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
22/07/2019	20h00	GlobeNewswire Inc.	ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals, Inc.; Trading Symbol Change to “HEPA”	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
28/06/2019	14h43	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
27/06/2019	14h00	GlobeNewswire Inc.	ContraVir Pharmaceuticals Submits IND Application for CRV431 for NASH	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
20/06/2019	22h30	GlobeNewswire Inc.	ContraVir Pharmaceuticals Receives Positive FDA Response to CRV431 Pre-IND Package for NASH	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
19/06/2019	23h26	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
18/06/2019	14h45	GlobeNewswire Inc.	ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
18/06/2019	12h01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
17/06/2019	14h00	GlobeNewswire Inc.	Compelling Positive Results Reported from Human Liver Experiments with ContraVir Pharmaceuticals’ NASH Drug Candidate	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
13/06/2019	22h37	Edgar (US Regulatory)	Withdrawal of a Registration Statement Withdrawal Request (rw Wd)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
13/06/2019	21h31	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
12/06/2019	16h57	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
12/06/2019	12h03	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
11/06/2019	14h30	GlobeNewswire Inc.	ContraVir Pharmaceuticals Announces Publication of CRV431 Data from Experimental Model of Hepatitis B	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
06/06/2019	14h00	GlobeNewswire Inc.	ContraVir Pharmaceuticals Sets the Stage for CRV431 Development in NASH with Positive Results from Second Model of Liver Fibr...	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
31/05/2019	14h00	GlobeNewswire Inc.	ContraVir Pharmaceuticals, Inc. Announces Reverse Stock Split	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
20/05/2019	20h46	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
06/05/2019	14h00	GlobeNewswire Inc.	ContraVir Pharmaceuticals Receives Positive Nasdaq Listing Decision	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
29/04/2019	14h30	GlobeNewswire Inc.	ContraVir Pharmaceuticals to Present at the 2019 ThinkEquity Conference	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
25/04/2019	15h02	GlobeNewswire Inc.	ContraVir Pharmaceuticals, Inc. Announces Pricing of $2.14 Million Public Offering	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
11/04/2019	14h00	GlobeNewswire Inc.	ContraVir Pharmaceuticals to Present CRV431 Phase 1 Data at the International Liver Congress™	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
02/04/2019	23h07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
02/04/2019	15h37	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
27/03/2019	20h45	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
18/03/2019	22h07	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)
14/03/2019	12h02	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:CTRV	Contravir Pharmaceuticals (MM)